Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age
Clinical trial NCT00249821 · COMPLETED
Trial details
- NCT number
- NCT00249821
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-28
- Primary completion
- 2007-09-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.